ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1932

Increasing Access to Inflammatory Arthritis Education in Rural and Remote Communities Using Telemedicine

Carol Kennedy1, Kelly Warmington2, Carol Flewelling3, Rachel Shupak4, Angelo Papachristos5, Caroline Jones6, Dorcas Beaton7, Sydney Brooks8 and Denise Linton9, 1Mobility Program Clinical Research Unit, St. Michael's Hospital, Toronto, ON, Canada, 2Learning Institute, The Hospital for Sick Children, Toronto, ON, Canada, 3St. Michael's Hospital, Toronto, ON, Canada, 4Rheumatology, St. Michael's Hospital, Toronto, ON, Canada, 5Physiotherapy, St Michael's Hospital, Toronto, ON, Canada, 6Mobility Program, St. Michael's Hospital, Aurora, ON, Canada, 7Research, Mobility Program Clinical Research Unit, Li Ka Shing Knowledge Institute, St. Michaels Hospital, Toronto, ON, Canada, 8The Arthritis Society, Ontario Division, Toronto, ON, Canada, 9Mobility Clinical Research Unit, St. Michael's Hospital, Toronto, ON, Canada

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Education, inflammatory arthritis and interdisplinary, patient

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Health Disparities/Social Determinants of Health

Session Type: Abstract Submissions (ARHP)

Background/Purpose: Telemedicine-based approaches to healthcare service delivery improve access to care. It was recognised that people with inflammatory arthritis living in rural areas had limited access to patient education and could benefit from the “Prescription for Education (RxEd)” program, an evidence-based inflammatory arthritis education program. (format: one-day, audience: adults with inflammatory conditions, facilitators: specialized arthritis care providers). The one-day program includes a variety of short presentations and panel discussions by the team, and small group, facilitator-led discussions. 

The program was adapted to be delivered via interactive videoconferencing through two workshops for local and rural facilitators: Telemedicine Best Practices/Adult Education Principles; Improved Public Speaking. 

The objective of this study was to evaluate the effectiveness of telemedicine delivery of “Prescription for Education” in improving arthritis self-efficacy and other secondary outcomes (arthritis knowledge, coping efficacy, illness intrusiveness, and effective consumer). 

Methods: Two group, pre-post design comparing two methods of delivery, local (I, in-person) versus videoconferencing (R, remote using telemedicine), of the RxEd program.

Data were collected at baseline (T1), immediately following RxEd (T2), and at 6 months (T3). Self-report questionnaires served as the data collection tool. Measures included demographics, disorder-related, Arthritis Self-Efficacy Scale (SE), arthritis knowledge [ACREU RA knowledge questionnaire (AK)], coping efficacy (CE), Illness Intrusiveness (II), and Effective Consumer Scale (ECS). Analyses included: Univariate statistics for primary and secondary outcomes; Repeated measures analyses of variance (MANOVA) to assess change in primary outcome (SE) across T1-3 (I vs R); and Repeated measures ANOVA to assess change from pre- to immediate-post (AK) and pre- to 6-month post (CE, II, ECS) (I vs R). 

Results: 123 persons completed baseline questionnaires (I n=36; R n=87), with follow-up of 81% (n=100) immediate post (T2) and 61% (n=75) at 6 months (T3). No significant baseline differences were found for: demographics, disorder-related, SE, AK, CE, II, and ECS measures. 

Both groups (I and R) showed immediate effect (improved SE) after the intervention that diminished slightly over 6 months. MANOVA significant across T1-3 p<0.001 for SE. No significant differences (SE p=0.31) between groups (I vs R). 

Both groups showed significant increase in knowledge (AK) from pre- to immediate post RxEd (p<0.0001), and no significant difference I vs R (ANOVA p=0.41). Both groups showed significant improvement in CE (p<0.0001), II (p=0.03), and ECS (p<0.0001) from pre- to 6-month follow-up. No significant differences (ANOVA, p-values 0.20 – 0.78) between groups (I vs R) for all secondary outcomes. 

Conclusion: Improvements in arthritis self-efficacy and other secondary outcomes were equally effective in local (in-person) and remote participant groups. Access to inflammatory arthritis education in rural and remote communities is greatly increased with using Telemedicine.


Disclosure:

C. Kennedy,

CIORA,

2,

Abbvie, Roche, UCB, Janssen,

9;

K. Warmington,
None;

C. Flewelling,
None;

R. Shupak,
None;

A. Papachristos,
None;

C. Jones,
None;

D. Beaton,
None;

S. Brooks,
None;

D. Linton,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/increasing-access-to-inflammatory-arthritis-education-in-rural-and-remote-communities-using-telemedicine/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology